Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Xu, G; Wang, YM; Ying, MM; Chen, SD; Li, ZR; Ma, HL; Zheng, MH; Wu, J; Ding, CM

Zheng, MH (corresponding author), Wenzhou Med Univ, NAFLD Res Ctr, Dept Hepatol, Affiliated Hosp 1, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.; Ding, CM (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Wenzhou 325035, Peoples R China.; Wu, J (corresponding author), Fudan Univ, Dept Med Microbiol, Key Lab Mol Virol, Sch Basic Med Sci, 138 Yixue Yuan Rd,POB 228, Shanghai 200032, Peoples R China.

CLINICAL AND MOLECULAR HEPATOLOGY, 2021; 27 (2): 329

Abstract

Background/Aims: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steato......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索